Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q4 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 229.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $229.74 | 52 Week High | $160.00 | |||
| Open | $229.74 | 52 Week Low | $95.80 | |||
| Day High | $229.74 | P/E | 42.70 | |||
| Day Low | $229.74 | EPS | $5.38 | |||
| Volume | 57 | |||||
